Weekly Bond Bulletin
Catching a blue wave
With markets increasingly expecting Joe Biden to win the US presidential election and the Democrats to take control of the Senate, should investors be moving to lower their duration positioning?
There are two narratives currently driving risk-on sentiment in bond markets: fiscal stimulus and a Covid vaccine. The US presidential election outcome will likely have an impact on the scale and timing of US fiscal stimulus measures and could also raise volatility. Polls are pointing towards a victory for Joe Biden and for Senate Democrats (a blue wave). While the accuracy of polling, particularly in light of the 2016 election outcome, is never certain, Biden has gathered a stronger lead than Clinton had at this stage in the campaign. As this year has progressed the narrative surrounding a Biden presidency has flipped, with previous concerns around increased regulation and higher corporate taxes replaced by hopes that a large fiscal stimulus programme would be put in place relatively quickly after the election (whereas issues such as tax reform would take longer to implement). Besides the US election, vaccine developments are also being watched closely by investors. An effective Covid vaccine should eventually allow in-person services to complete the recovery already largely achieved by retail sales and manufacturing. While we can’t predict the timing, we do know that advanced vaccine trials are still targeting an efficacy signal by late October or early November.
US election polling is swinging in favour of Biden
Source: Real Clear Politics; data as of 13 October 2020.
Since reaching a floor of 0.51% in August, the benchmark US 10-year Treasury yield has gradually increased to a current level of 0.73% as investors have priced in the prospect of a blue wave in the US election. We had expected Treasuries to remain at the lower end of a 0.5%-1.0% range until a change in the macro outlook, such as a vaccine or a Democratic sweep, pushed them higher. Since the chances of these two catalysts have recently increased, we now expect Treasuries to move towards the higher end of that range before year end. In terms of relative valuations, we think German Bund yields may also move higher, but to a lesser extent than US Treasuries, especially as the European Central Bank is likely to extend quantitative easing in December. (All data as of 13 October 2020).
Investors have already been shifting gears in their portfolios as markets have started to price in a Biden victory and a vaccine, with duration positioning surveys suggesting a move broadly to a more neutral, or short position. If a Biden victory or blue wave does occur, supply of US Treasuries would be expected to increase in order to fund the touted fiscal spending measures. Overall, a larger pool of debt with less buying appetite from investors should allow bond yields in the US to drift higher.
What does this mean for fixed income investors?
We think the recent reduction in investors’ duration positioning is justified, given increasing market expectations of a Biden victory and the development of an effective Covid vaccine. However, we are wary of a potential lag effect. For example, in the event of a blue wave in the US election, there would be a lag between the election result and the implementation of fiscal stimulus measures. And with the development of a vaccine, even if an effective vaccine is approved it will take time for it to be widely distributed. Nonetheless, we would expect markets to react significantly to either eventuality and therefore believe that it may be the right time to reduce duration in portfolios, albeit not holding an outright short position quite yet.
About the Bond Bulletin
Each week J.P. Morgan Asset Management’s Global Fixed Income, Currency and Commodities group reviews key issues for bond investors through the lens of its common Fundamental, Quantitative Valuation and Technical (FQT) research framework.Click here to read more about our FQT capabilities
FOR INSTITUTIONAL / WHOLESALE / PROFESSIONAL CLIENTS AND QUALIFIED INVESTORS ONLY – NOT FOR RETAIL USE OR DISTRIBUTION
The views contained herein are not to be taken as advice or a recommendation to buy or sell any investment in any jurisdiction, nor is it a commitment from J.P. Morgan Asset Management or any of its subsidiaries to participate in any of the transactions mentioned herein. Any forecasts, figures, opinions or investment techniques and strategies set out are for information purposes only, based on certain assumptions and current market conditions and are subject to change without prior notice. All information presented herein is considered to be accurate at the time of production. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine, together with their own professional advisers, if any investment mentioned herein is believed to be suitable to their personal goals. Investors should ensure that they obtain all available relevant information before making any investment. It should be noted that investment involves risks, the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested. Both past performance and yield are not a reliable indicator of current and future results.